Swedish Orphan Biovitrum Logo

Swedish Orphan Biovitrum

🇸🇪
SOBI
SE0000872095

Swedish Orphan Biovitrum (Sobi) is a leading specialty pharmaceutical company that develops and markets innovative orphan drugs for rare diseases. Sobi focuses on biopharmaceuticals in hemophilia, immunology, and other therapeutic areas to sustainably improve the lives of patients.

Next Quarterly Earnings

Tuesday, October 27, 2026
CW 44
Pre-Market
In 61 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on September 29, 2026

Stock Price

Frequently asked questions

When will Swedish Orphan Biovitrum report its next quarterly earnings?

Swedish Orphan Biovitrum is scheduled to report its next quarterly earnings on 10/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Swedish Orphan Biovitrum last report quarterly earnings?

Swedish Orphan Biovitrum last reported quarterly earnings on 7/16/2026 (Q2 2026). Earnings per share (EPS) came in at 3.14 SEK.

How does Swedish Orphan Biovitrum stock react to earnings?

Across its last 5 earnings reports, Swedish Orphan Biovitrum stock moved by ±2.7% on average the following day. The largest reaction was +8% on 02/05/2026; 3 of 5 reactions were positive.

How often has Swedish Orphan Biovitrum beaten expectations?

Swedish Orphan Biovitrum has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).

How do I add the Swedish Orphan Biovitrum earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:SEK 6.26
Actual:
Q2 2026
Missed
Estimate:SEK 3.40
Actual:SEK 3.14
Difference:-SEK 0.26
Price reaction (1 day):+2.2 %
Price reaction (7 days):+0.5 %
Q1 2026
Beat
Estimate:SEK 3.63
Actual:SEK 3.81
Difference:+SEK 0.18
Price reaction (1 day):+1.2 %
Price reaction (7 days):+8.9 %
Q4 2025
Beat
Estimate:SEK 4.22
Actual:SEK 5.39
Difference:+SEK 1.17
Price reaction (1 day):+8.0 %
Price reaction (7 days):+14.6 %
Q3 2025
Beat
Estimate:$4.99
Actual:$6.05
Difference:+$1.06
Price reaction (1 day):-1.9 %
Price reaction (7 days):+4.0 %
Q1 2025
Beat
Estimate:$1.61
Actual:$2.36
Difference:+$0.75
Q4 2024
Estimate:
Actual:
Price reaction (1 day):-0.2 %
Price reaction (7 days):-2.3 %

Earnings statistics

Stock reaction to earnings

±2.7%
Avg. next-day move
+8%
Largest move (02/05/2026)
60%
Share of positive reactions
±6.1%
Avg. move after 7 days

Basis: price reactions to the last 5 report dates (close to close).

Estimates vs. results

4/5
Quarters above estimates
80%
Beat rate
+5.1%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Swedish Orphan Biovitrum
Ticker Symbol
SOBI
ISIN
SE0000872095
Country
🇸🇪
Sweden
Sector